In Advanced CKD, Metformin Associated with Increased Mortality Risk (FREE)
By Kelly Young Edited by André Sofair, MD, MPH Metformin use is associated with increased mortality in patients with advanced chronic kidney disease (CKD), according to a retrospective, observational study in the Lancet Diabetes & Endocrinology. (Metformin is contraindicated … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - June 19, 2015 Category: Primary Care Source Type: news

AstraZeneca and University of Michigan partner to advance treatments for CKD
AstraZeneca has entered a two-year research collaboration with the University of Michigan to advance treatments for chronic kidney disease (CKD). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - June 16, 2015 Category: Pharmaceuticals Source Type: news

Uganda: Kidney Disease Treatment Not for All
[IPS] Kampala -Vincent Mugyenyi, a 65-year-old retired pilot from the Ugandan Air Force, has lost count of how many dialysis treatment slots he has had to attend in the eight years he has been fighting chronic kidney disease. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 16, 2015 Category: African Health Source Type: news

Prevalence and Correlates of Gout in a Large Cohort of Patients With Chronic Kidney DiseasePrevalence and Correlates of Gout in a Large Cohort of Patients With Chronic Kidney Disease
What does this new epidemiological study tell us about the pathophysiology and prevalence of gout in patients with CKD? Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 1, 2015 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Roche enters into exclusive license agreement with Galenica for the commercialisation of Mircera in the United States
Roche announced today that it has entered into an exclusive licence agreement with Galenica for the commercialisation of Roche's drug Mircera (methoxy polyethylene glycol-epoetin beta) in the US and Puerto Rico. Mircera is a prescription medicine used to treat symptomatic anaemia associated with chronic kidney disease (CKD) in adult patients and represents an ideal complement to the existing product portfolio of Galenica for patients with CKD and iron deficiency. (Source: Roche Investor Update)
Source: Roche Investor Update - May 28, 2015 Category: Pharmaceuticals Source Type: news

Duration of CKD and Executive Function in Pediatric PatientsDuration of CKD and Executive Function in Pediatric Patients
Is there an established connection between chronic kidney disease and reduced attention and executive function in pediatric patients, and does duration of disease play a role? Kidney International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 27, 2015 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Blood Pressure Control in Chronic Kidney DiseaseBlood Pressure Control in Chronic Kidney Disease
This study suggests that lower is not always better. Evidence-Based Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 27, 2015 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Which Blood Pressure-Lowering Strategy for Patients with Diabetes and Chronic Kidney Disease? (FREE)
By Amy Orciari Herman Edited by Jaye Elizabeth Hefner, MD Findings from a network meta-analysis in the Lancet may help guide decisions regarding blood pressure-lowering therapy in patients with diabetes and chronic kidney disease (CKD).Researchers examined nearly 160 … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - May 26, 2015 Category: Primary Care Source Type: news

Best and safest blood pressure treatments in kidney, diabetes patients compiled
The first definitive summary of the best and safest blood pressure lowering treatments for kidney disease and diabetes patients has been compiled by clinicians. Diabetes and high blood pressure are the most common causes of kidney disease around the world, and people often have both. Chronic kidney disease caused by diabetes always affects both kidneys and generally gets worse over time, often leading to kidney failure requiring dialysis treatment or a kidney transplant. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 22, 2015 Category: Science Source Type: news

Improving Identification, Management of CKD in Primary CareImproving Identification, Management of CKD in Primary Care
Identification of early-stage chronic kidney disease in primary care remains inconsistent. In this article, the authors describe an evidence-based, collaborative framework to address this problem. International Journal for Quality in Health Care (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 20, 2015 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news

Study suggests need for renal protective care in pediatric lung transplant patients
Caucasian and Hispanic children who undergo lung transplantation appear to be at greater risk for developing chronic kidney disease, or CKD, than other children, according to a small retrospective study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 17, 2015 Category: Science Source Type: news

​A battle brews between Baupost Group and short investors drug firm Keryx
This Friday could be an eye-opener for the many investors betting against Boston-based Keryx Biopharmaceuticals. That’s when its biggest investor will reveal whether it’s standing firm or cutting its losses following months of share declines. Boston-based Keryx (Nasdaq: KERX) has seen an increase in the volume of “short interest” — investors who profit from stock losses, rather than gains — over the past year as it’s launched its drug, Auryxia, for chronic kidney disease. Perhaps anticipating… (Source: bizjournals.com Health Care:Hospitals headlines)
Source: bizjournals.com Health Care:Hospitals headlines - May 12, 2015 Category: Hospital Management Authors: Don Seiffert Source Type: news

Dexamethasone May Help Prevent Severe Kidney Injury Following Heart Surgery
Acute kidney injury can be a serious complication following heart surgery. Patients who received dexamethasone during heart surgery had about a 2.5-times lower risk of developing kidney failure requiring dialysis compared with those receiving a placebo, research concludes. The greatest benefits of dexamethasone were seen in patients with pre-existing advanced chronic kidney disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 8, 2015 Category: Science Source Type: news

Hopelessness, suicide ideation, and depression in chronic kidney disease patients on hemodialysis or transplant recipients - Andrade SV, Sesso R, Diniz DH.
INTRODUCTION: Hopelessness, suicide ideation and depression symptoms affect life quality and expectancy of chronic kidney disease patients. OBJECTIVE: To verify whether there are differences in hopelessness, suicide ideation and depression symptoms... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - May 7, 2015 Category: Global & Universal Tags: Suicide and Self-Harm Source Type: news

Drugs in the Elderly With Chronic Kidney DiseaseDrugs in the Elderly With Chronic Kidney Disease
Elderly patients with CKD are particularly prone to drug-related adverse events. How can they be prevented, and how can clinicians advise their patients about the dangers of some medications? Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 4, 2015 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Walking For An Extra 2 Minutes Per Hour Can Help You Live Longer
Next time you get up and walk to the bathroom, you can feel good about doing something positive for your health. Seriously, though. New research suggests that even casually walking for an extra two minutes each hour may help you live a longer life. For the observational study, researchers from Northwestern Medical School analyzed data from 3,626 participants in an existing study on aging, and followed up with them for three years. They found that trading two minutes per hour of sedentary activity for normal-paced walking was associated with a one-third lower risk of dying. Among individuals with chronic kidney disease,...
Source: Healthy Living - The Huffington Post - May 1, 2015 Category: Consumer Health News Source Type: news

Walking Instead of Sitting Prolongs Life, Even in Small DosesWalking Instead of Sitting Prolongs Life, Even in Small Doses
Trading 2 minutes/hour of sedentary activity with light-intensity activity was linked to 33% lower mortality in the general population and 41% lower mortality in those with chronic kidney disease. Medscape Medical News (Source: Medscape PublicHealth Headlines)
Source: Medscape PublicHealth Headlines - May 1, 2015 Category: Primary Care Tags: Nephrology News Source Type: news

Merck Announces Results from Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Dateline City: VIENNA C-SURFER Trial is First to Investigate an All-Oral Ribavirin-Free Hepatitis C Treatment Regimen in Treatment-Naïve and Treatment-Experienced Patients with Advanced Chronic Kidney Disease Infected with Hepatitis C Virus Genotype 1 VIENNA--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the first presentation of data from C-SURFER, the company’s Phase 2/3 clinical trial evaluating the investigational once-daily treatment regimen of grazoprevir (100mg...
Source: Merck.com - Research and Development News - April 23, 2015 Category: Pharmaceuticals Tags: Hepatitis C Newsroom Research and Development News Corporate News Latest News Source Type: news

Socioeconomic Status and Chronic Kidney Disease in the USSocioeconomic Status and Chronic Kidney Disease in the US
Chronic kidney disease is more prevalent in those of low socioeconomic status. What potentially modifiable factors put this group at greater risk? American Journal of Epidemiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 10, 2015 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

New high-throughput screening method may uncover novel treatments for kidney disease
Researchers have developed a system that could be used to identify novel drug candidates that protect the function of the kidney cells that are damaged in patients with chronic kidney disease. One drug identified through the system effectively protected the kidney cells of rodents exposed to kidney damaging agents. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 9, 2015 Category: Science Source Type: news

Grazoprevir/Elbasvir, Merck’s Investigational Chronic Hepatitis C Therapy, Granted FDA Breakthrough Therapy Designations; New Phase 2 and 3 Data in Multiple HCV Patient Types to be Presented at The International Liver CongressTM 2015
Dateline City: KENILWORTH, N.J. Congress Highlights Include Results from Trials in a Wide Range of HCV Patients -- Patients with Chronic Kidney Disease, HIV Co-infection, Cirrhosis, and Prior Treatment Failures Company Remains on Track for NDA Filing with the U.S. FDA During First Half of 2015 KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced that grazoprevir/elbasvir, an investigational single tablet regimen for the treatment of chronic hepatitis C virus (HC...
Source: Merck.com - Corporate News - April 8, 2015 Category: Pharmaceuticals Tags: Hepatitis C Newsroom Corporate News Latest News Source Type: news

Grazoprevir/Elbasvir, Merck’s Investigational Chronic Hepatitis C Therapy, Granted FDA Breakthrough Therapy Designations; New Phase 2 and 3 Data in Multiple HCV Patient Types to be Presented at The International Liver CongressTM 2015
Dateline City: KENILWORTH, N.J. Congress Highlights Include Results from Trials in a Wide Range of HCV Patients -- Patients with Chronic Kidney Disease, HIV Co-infection, Cirrhosis, and Prior Treatment Failures Company Remains on Track for NDA Filing with the U.S. FDA During First Half of 2015 KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced that grazoprevir/elbasvir, an investigational single tablet regimen for the treatment of chronic hepatitis C virus (HCV) infection, has received two ...
Source: Merck.com - Corporate News - April 8, 2015 Category: Pharmaceuticals Tags: Corporate News Latest News Source Type: news

Treating a common gum condition could reduce risk of heart attacks in kidney disease patients
Treating a common gum condition in chronic kidney disease (CKD) patients could significantly reduce their risk of potentially fatal heart disease, researchers say. Over 10% of the adult population have CKD and those affected often have poor health outcomes due to an increased incidence of cardiovascular disease compared to the general population. CKD progressively worsens kidney function, raises blood pressure, and can cause progressive vascular injury and heart disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 1, 2015 Category: Science Source Type: news

FDA Gives Anemia Drug a Boxed Warning (FREE)
By Kristin J. Kelley Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD Ferumoxytol (Feraheme), the intravenous iron-replacement drug indicated for anemic adults with chronic kidney disease, will now carry a boxed warning about … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 31, 2015 Category: Primary Care Source Type: news

Oral drug normalizes blood potassium in 98 percent of kidney patients
A medication called ZS-9 normalized potassium in the blood of 98 percent of chronic kidney disease patients treated for hyperkalemia. Hyperkalemia is high potassium in the blood, and may occur as a side effect of taking kidney disease medications called Renin Angiotensin Aldosterone System inhibitors. Hyperkalemia increases the risk of cardiac arrhythmias. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 30, 2015 Category: Science Source Type: news

Oral drug normalizes blood potassium in 98 percent of kidney patients
(University of Texas Health Science Center at San Antonio) A medication called ZS-9 normalized potassium in the blood of 98 percent of chronic kidney disease patients treated for hyperkalemia. Hyperkalemia is high potassium in the blood, and may occur as a side effect of taking kidney disease medications called Renin Angiotensin Aldosterone System inhibitors. Hyperkalemia increases the risk of cardiac arrhythmias. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 30, 2015 Category: Global & Universal Source Type: news

Metformin in Patients With CKD: A New AnalysisMetformin in Patients With CKD: A New Analysis
A large systematic review revisits the notion that metformin should be avoided in all patients with chronic kidney disease. Medscape Nephrology (Source: Medscape Nephrology Headlines)
Source: Medscape Nephrology Headlines - March 23, 2015 Category: Urology & Nephrology Tags: Nephrology Viewpoint Source Type: news

Scientists uncover predictors of chronic kidney disease worsening in children, adolescents
New insights into why a child's chronic kidney disease (CKD) may worsen to kidney failure have been uncovered through a new study. Among nearly 500 children and adolescents with mild to moderate CKD, researchers identified factors, such as high blood pressure, protein loss from the kidneys, and anemia, that predicted disease worsening but that could be treated to ideally change the course of the disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 19, 2015 Category: Science Source Type: news

La Jolla begins Phase IIb trial of GCS-100 to treat advanced CKD
US-based biotechnology firm La Jolla Pharmaceutical has started a Phase IIb clinical trial of its galectin-3 inhibitor, GCS-100, to treat advanced chronic kidney disease (CKD) caused by diabetes. (Source: Drug Development Technology)
Source: Drug Development Technology - March 19, 2015 Category: Pharmaceuticals Source Type: news

Relypsa Announces Phase 2 Data Showing Efficacy of Patiromer FOS in Heart Failure Patients With Chronic Kidney Disease at ACC Scientific Session
(Source: Medical News (via PRIMEZONE))
Source: Medical News (via PRIMEZONE) - March 14, 2015 Category: Pharmaceuticals Source Type: news

Chronic Kidney Disease May Increase Certain Risks During Pregnancy
Among pregnant women, the risk for adverse pregnancy outcomes—such as preterm delivery or the need for neonatal intensive care—increased across stages of chronic kidney disease, a study concludes. The risks of intrauterine death or fetal malformations were not higher in women with chronic kidney disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 12, 2015 Category: Science Source Type: news

Kidney Disease Can Pose Problems During Pregnancy, Study Warns
Careful monitoring necessary, researchers say Source: HealthDay Related MedlinePlus Pages: Childbirth Problems, Chronic Kidney Disease, Health Problems in Pregnancy (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - March 12, 2015 Category: Consumer Health News Source Type: news

New website aims to improve understanding of chronic kidney disease
A new website is launched today that will help bridge the communication gap between healthcare professionals and patients diagnosed with mild chronic kidney disease (CKD) after research revealed a disparity between what GP’s explain and what patients understand about the condition. The resource has been developed by University of Bristol academics. (Source: University of Bristol news)
Source: University of Bristol news - March 12, 2015 Category: Universities & Medical Training Tags: Research; Institutes, Elizabeth Blackwell, Faculty of Medicine and Dentistry, School of Social and Community Medicine; Press Release Source Type: news

How the United States Stacks Up to Other Countries in Chronic Kidney Disease
Patients sometimes tell me in research interviews that they intentionally compare themselves to other patients who are worse off to make themselves feel better. Comparing ourselves to others who may be better or worse off can give us ideas for improving our own health. Similarly, the United States should compare itself to other countries to improve our health outcomes. In the case of kidney disease, World Kidney Day on March 12 draws our attention to international comparisons of health. Chronic kidney disease is a growing public health problem in this country and around the world. So it is important for all countries to...
Source: Healthy Living - The Huffington Post - March 11, 2015 Category: Consumer Health News Source Type: news

Low-protein Diets in Chronic Kidney DiseaseLow-protein Diets in Chronic Kidney Disease
What does the latest science tell us about the effects of a low-protein intake in patients with CKD? Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 9, 2015 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Kidney treatment developer Tricida raises $30M in Series B
Biotech firm Tricida raised $30 million in Series B funding on Wednesday to take its chronic kidney disease treatment into clinical trials. Existing investor OrbiMed led the round with participation by Sibling Capital Ventures and Limulus Venture Partners. The company has raised $44.5 million to date. CEO Gerrit Klaerner heads up the South San Francisco-based company, which was founded in 2013. Klaerner co-founded Ilypsa in 2003 to develop renal care pharmaceutical products, selling the company… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 5, 2015 Category: Pharmaceuticals Authors: Gina Hall Source Type: news

Is long-term paracetamol use not as safe as we thought?
Conclusion This is a valuable review that has searched the literature and identified eight observational studies in adults that have looked at the adverse effects that may be associated with paracetamol use. As the researchers say, it will add to information on the potential harms of paracetamol – an area where up-to-date information has been lacking. The studies included very large population sizes, and collectively provide some evidence suggesting potential effects upon the cardiovascular system, kidney and gastrointestinal system. There was also a suggestion of increased risk of all-cause mortality. Howe...
Source: NHS News Feed - March 3, 2015 Category: Consumer Health News Tags: Heart/lungs Medication Source Type: news

Antiretrovirals Linked to Cumulative Kidney RiskAntiretrovirals Linked to Cumulative Kidney Risk
The chance of developing chronic kidney disease increases steadily in patients taking tenofovir, ritonavir-boosted atazanavir, or ritonavir-enhanced lopinavir, researchers warn. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 27, 2015 Category: Consumer Health News Tags: HIV/AIDS News Source Type: news

Amgen Drug Shows Positive Results in Late-Phase Study
A late-phase clinical study of Amgen Inc.’s experimental treatment for secondary hyperparathyroidism in patients with chronic kidney disease showed a higher percentage of patients responded to its treatment. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 25, 2015 Category: Pharmaceuticals Tags: PAID Source Type: news

Save Money, Save Lives: Why the Silence on the Fiscal and Fatal Consequences of Kidney Disease Matters
Saving lives is about more than media awareness of a disease. It is about doctors making sure their patients understand all risks for a disease. And ultimately that saves lives and money. Breast cancer awareness, for instance, is aided by high profile public efforts such as the Avon 39: The Walk to End Breast Cancer, or the Susan G. Komen Race for the Cure. Even when using what many criticize as misguided language concerning cancer survivors, the blog about a Komen ad this week went viral, bringing even more media attention. February is Heart Health Month, and millions wore red recently to demonstrate the need for hea...
Source: Healthy Living - The Huffington Post - February 25, 2015 Category: Consumer Health News Source Type: news

Diet high in red meat may make kidney disease worse
(Texas A&M University) An estimated 26 million people in the United States have chronic kidney disease, which can lead to complete kidney failure. Once the kidneys fail, patients either need to undergo dialysis treatments three times a week or have a kidney transplant to remain alive. In 2013, more than 47,000 Americans died from kidney disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 23, 2015 Category: Global & Universal Source Type: news

Meat-Heavy, High-Acid Diet Poses Risk for Those with Kidney Disease
Switching to regimen higher in fruits, veggies might help stave off organ failure, experts say Source: HealthDay Related MedlinePlus Pages: Chronic Kidney Disease, Dietary Proteins, Diets (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - February 13, 2015 Category: Consumer Health News Source Type: news

Hope for Sugar Cane Workers Who Bear CKD Burden
(MedPage Today) -- Photographer Ed Kashi sheds light on the epidemic of chronic kidney disease in Central America and why it's preventable. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 6, 2015 Category: Cardiology Source Type: news

BU study finds occupational link in kidney disease epidemic in Central America
(Boston University Medical Center) Sugarcane workers in northwestern Nicaragua experienced a decline in kidney function during the harvest, with field workers at greatest risk, suggesting that heat stress or other occupational factors may be playing a role in the high rates of chronic kidney disease in the region, a new study led by Boston University School of Public Health researchers shows. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 2, 2015 Category: Global & Universal Source Type: news

Chronic kidney disease and recurrent falls in nursing home residents: A retrospective cohort study - Hall RK, Landerman LR, O'Hare AM, Anderson RA, Colón-Emeric CS.
This study examined whether chronic kidney disease (CKD) is associated with recurrent falls in older adults in nursing homes (NHs). We used data abstracted over a six month period from 510 NH residents with a history of falls. Thirty-five percent of the NH... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - January 31, 2015 Category: Global & Universal Tags: Age: Elder Adults Source Type: news

Gut bacteria byproduct linked to chronic kidney disease for the first time
For the first time, researchers have linked trimethylamine N-oxide -- a gut metabolite formed during the digestion of egg-, red meat- or dairy-derived nutrients choline and carnitine -- to chronic kidney disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 29, 2015 Category: Science Source Type: news

NICE online learning tool for healthcare professionals who manage lipid modification
Developed by the Centre for Pharmacy Postgraduate Education, the tool supports the implementation of NICE guideline 181, Lipid modification, and uses interactive activities, podcast and video to support the assessment and treatment of people at risk of cardiovascular disease (CVD) and people who have had previous cardiovascular disease. The guideline offers evidence-based advice on care and treatment and also updates recommendations for people with chronic kidney disease, type 1 and type 2 diabetes. NICE has also produced a video about the tool. (Source: NHS Networks)
Source: NHS Networks - January 28, 2015 Category: UK Health Authors: Maria Axford Source Type: news

Unlocking the kidney riddle in newborns
Researchers are closer to understanding why babies born with smaller kidneys have a high risk of developing cardiovascular disease. Currently, renal disorders at birth affect about one in 500 babies. Many of these babies go on to lead healthy normal lives, however 20-40 per cent will develop chronic kidney disease and high blood pressure. Unfortunately, these conditions are the main cause of end-stage kidney disease and the need for dialysis in children. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 27, 2015 Category: Science Source Type: news

FDA approves Rockwell Medical's iron replacement drug
(Reuters) - The Food and Drug Administration approved Rockwell Medical Inc's drug for treating iron loss in chronic kidney disease patients on dialysis, sending the company's shares up about 15 percent in premarket trading. (Source: Reuters: Health)
Source: Reuters: Health - January 26, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

Herbs and hazards: risk of Aristolochic acid nephropathy in Iran - Ardalan MR, Khodaie L, Nasri H, Jouyban A.
Herbs are usually considered as inherently harmless products. Nonetheless, various renal injuries have been reported in association with several herbs. The best-known herb-induced chronic kidney disease is aristolochic acid nephropathy. Aristolochic acid i... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - January 24, 2015 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news